We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
PIMCO Short Term Municipal Bond Active Exchange-Traded Fund
SMMU
$1.22B
| $1.35K | ﹤0.01% |
+27
| New | +$1.35K |
2025 Q2
0 quarters
|
|
3102
Park Aerospace
PKE
$571M
| $1.35K | ﹤0.01% |
91
| – | – |
2021 Q4
14 quarters
|
|
3103
DELISTED
Anywhere Real Estate
HOUS
| $1.35K | ﹤0.01% |
372
-1,255
| -77% | -$4.38K |
2024 Q3
3 quarters
|
|
3104
Amplify Junior Silver Miners ETF
SILJ
$3.32B
| $1.35K | ﹤0.01% |
91
| – | – |
2024 Q4
2 quarters
|
|
3105
DELISTED
Berry Corp
BRY
| $1.33K | ﹤0.01% |
481
-264
| -35% | -$705 |
2019 Q4
22 quarters
|
|
3106
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $1.33K | ﹤0.01% |
27
| – | – |
2020 Q2
20 quarters
|
|
3107
State Street SPDR Portfolio TIPS ETF
SPIP
$1.04B
| $1.33K | ﹤0.01% |
51
| – | – |
2024 Q3
3 quarters
|
|
3108
Canopy Growth
CGC
$311M
| $1.32K | ﹤0.01% |
1,086
+160
| +17% | +$213 |
2018 Q3
27 quarters
|
|
3109
Franklin Covey
FC
$205M
| $1.32K | ﹤0.01% |
58
+52
| +867% | +$1.15K |
2024 Q3
3 quarters
|
|
3110
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$330M
| $1.32K | ﹤0.01% |
+11
| New | +$1.28K |
2025 Q2
0 quarters
|
|
3111
ServisFirst Bancshares
SFBS
$4.33B
| $1.32K | ﹤0.01% |
34
-64
| -65% | -$2.36K |
2021 Q2
16 quarters
|
|
3112
Silvercorp Metals
SVM
$2.16B
| $1.32K | ﹤0.01% |
312
| – | – |
2024 Q3
3 quarters
|
|
3113
DELISTED
MRC Global
MRC
| $1.32K | ﹤0.01% |
96
+85
| +773% | +$1.02K |
2022 Q3
11 quarters
|
|
3114
BrightView Holdings
BV
$975M
| $1.31K | ﹤0.01% |
79
| – | – |
2022 Q2
12 quarters
|
|
3115
Simmons First National
SFNC
$3.22B
| $1.31K | ﹤0.01% |
69
| – | – |
2017 Q3
31 quarters
|
|
3116
Invesco Pharmaceuticals ETF
PJP
$559M
| $1.3K | ﹤0.01% |
16
| – | – |
2023 Q3
7 quarters
|
|
3117
Mid Penn Bancorp
MPB
$911M
| $1.3K | ﹤0.01% |
+46
| New | +$1.24K |
2025 Q2
0 quarters
|
|
3118
Home BancShares
HOMB
$5.78B
| $1.28K | ﹤0.01% |
45
-254
| -85% | -$7.07K |
2019 Q1
25 quarters
|
|
3119
DELISTED
Flushing Financial
FFIC
| $1.27K | ﹤0.01% |
107
-132
| -55% | -$1.59K |
2023 Q1
9 quarters
|
|
3120
Installed Building Products
IBP
$5B
| $1.26K | ﹤0.01% |
7
-24
| -77% | -$3.99K |
2024 Q1
5 quarters
|
|
3121
Axsome Therapeutics
AXSM
$8.47B
| $1.25K | ﹤0.01% |
12
-3
| -20% | -$318 |
2024 Q2
4 quarters
|
|
3122
Edgewise Therapeutics
EWTX
$4.15B
| $1.25K | ﹤0.01% |
95
-38
| -29% | -$548 |
2023 Q4
6 quarters
|
|
3123
United States Oil Fund
USO
$2.02B
| $1.24K | ﹤0.01% |
17
| – | – |
2024 Q3
3 quarters
|
|
3124
BioAge Labs
BIOA
$246M
| $1.24K | ﹤0.01% |
300
-431
| -59% | -$1.74K |
2024 Q3
3 quarters
|
|
3125
MBX Biosciences
MBX
$2.44B
| $1.23K | ﹤0.01% |
+108
| New | +$1.1K |
2025 Q2
0 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.